It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is ...
Soleno Therapeutics ( ($SLNO) ) has released its Q4 earnings. Here is a breakdown of the information Soleno Therapeutics presented to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback